Timely treatment of heart attacks: Results from the AMI-QUEBEC Study

December 04, 2006

Huynh and coauthors report the findings of the AMI-QUEBEC Study, which looked at delays in providing reperfusion therapy, potentially life-saving treatment to restore blood flow to the heart muscle, to patients with ST-segment elevation acute myocardial infarction (STEMI) who were admitted to 17 hospitals in Quebec in 2003. They also identify factors associated with the failure to deliver reperfusion therapy within recommended times.

The success of reperfusion therapy depends on how much time has passed from the onset of a heart attack to the administration of the treatment (often termed "door-to-needle" time if fibrinolytic therapy is given and "door-to-balloon" time if percutaneous coronary intervention [PCI], or balloon angioplasty, is used).

The authors found that almost half of the patients who received fibrinolytic therapy were treated within 30 minutes, a substantial improvement over the median door-to-needle time of 85 minutes reported during 1991/92, when only 3% of Canadian patients were treated within 30 minutes. However, they found that door-to-balloon times exceeded current recommended times in the majority of patients.
-end-
p. 1527 Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study
http://www.cmaj.ca/pressrelease/pg1527.pdf

Canadian Medical Association Journal

Related Treatment Articles from Brightsurf:

Treatment for teen anxiety
In a new National Institute of Mental Health-funded study, led by Jeffrey Strawn and published in the Journal of Clinical Psychiatry, UC researchers took a first look at one particular medication for treatment of anxiety disorders in pediatric patients to see if it was beneficial.

A sound treatment
University of Utah biomedical engineering assistant professor Jan Kubanek has discovered that sound waves of high frequency (ultrasound) can be emitted into a patient's brain to alter his or her state.

A new treatment for liver cancer
In the latest issue of Molecular Therapy, Skoltech and MIT researchers have published a new combinatorial therapy for the treatment of liver cancer.

Improving the treatment of periodontitis
For the first time, researchers from Charité -- Universitätsmedizin Berlin have shown that a unicellular parasite commonly found in the mouth plays a role in both severe tissue inflammation and tissue destruction.

Excellent long-term stability of treatment gains of stepwise treatment for pediatric OCD
A study in the Journal of the American Academy of Child and Adolescent Psychiatry (JAACAP), published by Elsevier, reports that the long-term stability of treatment gains for children and adolescents diagnosed with obsessive-compulsive disorder (OCD), participating in a stepwise manualized treatment, is excellent.

When the best treatment for hypertension is to wait
A new study concluded that a physician's decision not to intensify hypertension treatment is often a contextually appropriate choice.

Is opioid treatment available to those who need it most?
The US opioid epidemic is still raging -- it's particularly pronounced in low-income areas and in those where people lack access to health care services, which includes cities in Michigan and across the Rust Belt.

Virus characteristics predict HIV treatment efficacy with antibody treatment
Current HIV-1 therapies have been proven to be highly effective in slowing the progression of the virus in the body with only minimal side effects.

Light therapy could replace opioids as main treatment for cancer treatment side effect
A worldwide coalition of researchers and clinicians has agreed that light therapy is among the most effective interventions for the prevention of oral mucositis, painful ulcers in the mouth resulting from cancer therapy.

Minimally invasive uterine fibroid treatment safer and as effective as surgical treatment
Uterine fibroid embolization (UFE) effectively treats uterine fibroids with fewer post-procedure complications compared to myomectomy, according to new research presented today at the Society of Interventional Radiology's 2019 Annual Scientific Meeting.

Read More: Treatment News and Treatment Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.